March 12, 2026 a 03:43 pm

SOLV: Fundamental Ratio Analysis - Solventum Corporation

Solventum Corporation Stock Image

Solventum Corporation, a cutting-edge healthcare company, shows a robust performance across its core segments. With its diversification in Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration, SOLV is well-positioned to meet diverse market demands. The stock demonstrates potential for stability given its strong fundamentals.

Fundamental Rating

The fundamental metrics for Solventum Corporation are strong, with the company achieving a rating of A-. Each metric showcases the company's sound financial health.

Category Score Visualization
Discounted Cash Flow 5
Return On Equity 5
Return On Assets 5
Debt To Equity 1
Price To Earnings 3
Price To Book 2

Historical Rating

Historical scores indicate consistent performance with slight deviations in the overall rating, reflecting market conditions and operational adjustments.

Date Overall DCF ROE ROA D/E P/E P/B
2026-03-12 4 5 5 5 1 3 2
Previous 0 5 5 5 1 3 2

Analyst Price Targets

Analysts provide optimistic forecasts with a high target of $105, a low of $77, giving a median of $100, and a consensus of $95.8.

High Low Median Consensus
$105 $77 $100 $95.8
SOLV Stock Chart

Analyst Sentiment

The stock sentiment reflects a positive outlook with several buy recommendations and limited sell options, indicating confidence in future performance.

Recommendation Count Distribution
Strong Buy 0
Buy 7
Hold 3
Sell 1
Strong Sell 0

Conclusion

Solventum Corporation shows a promising path forward, driven by robust fundamentals and diverse market engagements. The stock is supported by a strong analyst consensus and price targets suggest a potential for growth. Although a high debt-to-equity ratio might pose a risk, the company's overall stability and market innovation mitigate potential downsides. Investors should be cautious of market volatility but can see consistent long-term value.